Clinical Research Guidelines A companion to the Textbook on Clinical Research: A Guide for Aspiring Professionals and Professionals Second Edition |
By Dr. Guru Prasad Mohanta |
US FDA Guideline
Clinical Trial
|
||||||||
|---|---|---|---|---|---|---|---|---|
US FDA Guideline |
||||||||
Clinical Trial |
||||||||
| Acceptance of Foreign Clinical studies | ||||||||
| Bioanalytical Method Validation Guidance for Industry | ||||||||
| Drug interaction studies - Study Design to Labelling | ||||||||
| Drug Metabolism and Interaction In Vitro studies | ||||||||
| Drug metabolism and Interaction studies In Vivo | ||||||||
| Exploratory IND Studies | ||||||||
| Exposure - Response Relationship | ||||||||
| Financial Discloure by Investigator | ||||||||
| Guidance for Institutional review Boards and Investigators | ||||||||
| Pharmacokinetics in Hepatic Impairments | ||||||||
| Pharmacokinetics in Pregnanacy | ||||||||
| Pharmacokinetics in Renal Impairments | ||||||||
| Phase1 Study Guidance for Industry | ||||||||
| Starting dose calculation | ||||||||
| Statement of Investigator | ||||||||
| Studies in special population-Geriatrics Guidance for Industry | ||||||||
| Guidance for Clinical Trial Sponsors | ||||||||
|
||||||||
| © 2017, Pharma Med Press ISBN: 978-93-5230-166-9 | ||||||||